G24.8
Conditions
Interventions
Group 1: Patient group with ADCY5-related dyskinesia who was prescribed theophylline by their attending physician
Using a questionnaire (uploaded as an attachment), anonymous data on symptoms, the hi
Sponsors
Medizinische Fakultät Leipzig
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Consent of the patients or guardians to the analysis of the anonymized data
Exclusion criteria
Exclusion criteria: no proof of ADCY5 mutation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Observation of therapeutic effects of theophylline on the symptoms of ADCY5 dyskinesia WHAT: Influence of theophylline on symptoms. WHEN: at a time chosen by the patient or family within the recruitment window. There is therefore no specification of a specific theophylline dose or a specific clinical condition. HOW: using a questionnaire: here a list of typical ADCY5-associated symptoms is offered and explained. The effects of theophylline are asked about using a Likert scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Tolerance of theophylline The questionnaire contains questions about adverse drug reactions (ADRs), which are answered by the patient/family. These ADRs are related to the indicated dose of theophylline. | — |
Countries
Australia, Germany, United States
Contacts
Public ContactAndreas Merkenschlager
Medizinische Fakultät Leipzig
Outcome results
None listed